Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy

• Status: Recruiting
• Trial end date: 2023-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

lactoferrin is believed to modulate immunity and help in prevention of recurrent bacterial vaginosis.In this study, the role of lactoferrin is assessed during third trimester of pregnancy.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zagazig University
• Treatments: Lactoferrin

Criteria

Inclusion Criteria:

1. Pregnant women of age group 20-37 years.

2. Primigravida.

3. 28-40 week gestation.

4. History of receurent bacterial vaginosis .

Exclusion Criteria:

1. Multiple gestations.

2. Multiparity.

3. Medical disorders as:

• Diabetes mellitus.

• Chronic hypertension.

• Endocrinal diseases.

• Autoimmune diseases.

• Renal diseases.

• Blood diseases.

4. Allergy to lactoferrin .